Cellyan Biotechnology Co., Ltd

Listed Company
HKPDCIK 0002007702NasdaqNon-AcceleratedEmerging GrowthWholesale-Drugs, Proprietaries & Druggists' SundriesE9KYFY ends Mar 31
Period
FY 2025
Revenue
Net Income
$-27.1K
Total Assets
$9.42M
Equity
Shares Out
11.00M
Op. Cash Flow

Business

Cellyan Biotechnology Co., Ltd provides cross-border OTC pharmaceutical e-commerce supply chain and procurement services through its Hong Kong subsidiaries. It offers one-stop services including product pre-consultation and review, HKDOH enlisting, import/export permits and customs clearance, temperature-controlled warehousing, packaging, value-added processing, and logistics and last-mile delivery, as well as procurement and distribution of enlisted OTC products. Its operations are organized into two divisions: Supply Chain Services and Procurement and Distribution. The company serves Mainland China e-commerce merchants and platform logistics partners (e.g., CaiNiao) sourcing products from Hong Kong, Taiwan, Japan and certain European countries.

Summary from filing dated 2025-08-14

Financials

Latest annual snapshot (FY2025, period end 2025-03-31). Full statement history unavailable for this entity.

Revenue
Net income$-27.1K
Total assets$9.42M
Total liabilities$4.43M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro